Topical Agents Containing Magnesium Sulfate & Wound Healing in the Rat Model

NCT04886882 — Early Phase 1, Unknown, 30 participants, Başakşehir Çam & Sakura City Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Effect of Topical Agents in Cream Formations Containing Magnesium Sulfate on Wound Healing in the Rat Model

RegistryNCT04886882
StatusUnknown
PhaseEarly Phase 1
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment30 (Estimated)
SponsorBaşakşehir Çam & Sakura City Hospital (Other gov); collaborators: Istanbul Kent University
ConditionsWound Heal
Interventionsplacebo comparator, sham comparator, Experimental drug 1, Experimental drug 2, Centella asiatica (Other, drug)
Datesstart 2021-03-22, primary completion 2021-06-01 (estimated), completion 2021-07-01 (estimated), first posted 2021-05-14, last updated 2021-05-14
Locations1 site in Turkey (Türkiye)

Related Papers Related Patents Related Grants Related Experts
All trials for Wound Heal All trials of placebo comparator All trials of sham comparator

-Summary

An experimental study examining wound healing in 5 different groups on 30 rats.

Expand all sections  ·  Collapse all

+Detailed description

Magnesium topically increases collagen synthesis and angiogenesis, providing faster and higher quality wound healing. In addition, with its analgesic effect, it will also eliminate the pain sensation caused by the wound and increase the quality of life of the patient whose skin integrity is impaired.

+Arms and interventions

ArmTypeInterventionsDescription
Group placeboPlacebo comparatorOther: placebo comparatorIsotonic solution will be administered daily to 6 female rats.
Group shamSham comparatorOther: sham comparatorBase cream to be applied twice a day to 6 female rats.
Group %1 mgso4ExperimentalOther: Experimental drug 1Cream containing 1% MgSO4 will be applied twice a day to 6 female rats.
Group %10 MgSO4ExperimentalOther: Experimental drug 2Cream containing 10% MgSO4 will be applied twice a day to 6 female rats.
Group positive controlActive comparatorDrug: Centella asiaticaCream containing centella asiatica will be applied twice a day to 6 female rats.
  • placebo comparator (Other): solution containing 0.9 % sodium chlorine
  • sham comparator (Other): vaseline, beeswax,polyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water
  • Experimental drug 1 (Other): A cream containing 10 % MgSO4.vaseline, beeswaxpolyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water
  • Experimental drug 2 (Other): A cream containing 10 % MgSO4.vaseline, beeswax,polyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water
  • Centella asiatica (Drug): A cream containing Centella asiatica

+Outcome measures

Primary outcomes

  • 7th day evaluation [7th day]: Histopathological evaluation of wound healing comparing with the rate of vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta) and hydroxyproline at immunohistochemical staining with biopsy on the 7th day.

Secondary outcomes

  • 15th day evaluation [15th day]: Histopathological evaluation of wound healing comparing with the rate of VEGF, TGF-beta and hydroxyproline at immunohistochemical staining with biopsy on the 15th day.

+Eligibility

Sex: Female, ages: 8 Weeks to 12 Weeks, accepts healthy volunteers

Inclusion Criteria:

* healthy rats between ages of 8- 12 weeks

Exclusion Criteria:

* weight loss of more than 15% of body weight

+Locations (1)

FacilityCityCountryStatus
Başakşehir Çam Ve Sakura HospitalIstanbulTurkey (Türkiye)